Definitive Contract 75N91021C00032
Award Date 9/16/21
Potential Completion Date 12/31/22
Potential Value $400K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Saratoga, CA 95070, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a $299,546.00 Firm Fixed Price contract to Woodtoga Holdings Company for the development of a novel electronic particle brachytherapy source. This Small Business set-aside contract has a completion date of September 24, 2014. Brachytherapy is a method of radiation therapy where a radiation source is placed inside or next to the area requiring treatment. This contract supports the National Cancer Institute's research and development efforts to advance...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Pact & Health LLC, a for-profit limited liability company located in Branford, Connecticut. The contract, awarded on September 11, 2019, has a potential value of $299,799.00 and is for the development of a versatile radiation-triggered phosphor platform for localized anti-cancer therapy. The contract is a...
- This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). The contract was awarded to Veloxai LLC, a self-certified small disadvantaged business, to develop an automatic treatment planning system for high-dose rate brachytherapy for cervical cancer in low-resource settings. The contract was set aside for total small businesses and has a completion date of September 14,...
- This $397,626 Firm Fixed Price contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Standard Imaging Inc., a small business manufacturer of radiation measurement equipment and software headquartered in Middleton, Wisconsin. The award is for the development of "A Novel Scintillation Detector System for Flash Radiation Therapy" under the NCI's Small Business Innovation Research (SBIR) program. This SBIR contract...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Radiologics, Inc., a for-profit organization. The contract, valued at $225,000.00, is for the development of FDA-compliant imaging informatics for cancer research under SBIR Topic 365. As a SBIR Phase I award, this contract is set aside for small businesses. The contract has a firm fixed price pricing type and was awarded on September 18, 2017, with...
- <p>This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), a civilian agency, to Sibtech, Inc., a for-profit manufacturer, in the amount of $2,256,052.35. The contract is for the development of systemic radionuclide therapy targeted to VEGF receptors in tumor vasculature. The contract has a firm fixed price pricing type and an ultimate completion date of October 31, 2021. This contract is a set-aside for small businesses.</p>
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Phase I contract to Radiopharmaceutical Imaging And Dosimetry, LLC (doing business as Radiopharmaceutical Imaging & Dosimetry LLC), a for-profit limited liability company. The $299,466.00 firm-fixed-price contract, which was set aside for small businesses, is for the development of user-friendly, platform-independent software to incorporate...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
- This is a $454,997 fixed-price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), to Ambay Immune Sensors And Controls, LLC, a woman-owned small business. The contract was awarded under the FY20 SBIR Phase I solicitation and is for the development of a "non-invasive, novel test to monitor biological response to radiotherapy" under Topic #400 - AMBAY RADI-SENSE. The contract...
- The National Cancer Institute awarded a $398,714 firm fixed-price contract to Irai Technologies, LLC, a small business based in Lutz, Florida, under the Small Business Innovation Research (SBIR) Program Phase I. The contract modification, effective September 23, 2024, extends the period of performance through September 22, 2026, and revises the Statement of Work and several contract sections at no additional cost to the government. The underlying solicitation sought development of a flash...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Woodtoga Holdings Company, a for-profit manufacturer, for the development of "Applicator-Compatible Electronic Brachytherapy Sources for Cancer Radiotherapy." The $399,779.00 firm fixed price contract runs through December 31, 2022 and is set aside for small businesses. This contract supports the SBIR program objectives to stimulate technological innovation and increase commercialization of federal research and development.
Generated 5/11/24, 10:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | $0 | 3/14/23 | |
| P00002 | Other Administrative Action | $0 | 9/2/22 | |
| P00001 | Other Administrative Action | $0 | 6/14/22 | |
| Not listed | Not listed | $399.8k | 9/16/21 |